• Submit
  • Personalize
    • Your alerts
    • Your lists
    • Your searches
  • Help
  • de
  • en
  • fr
  • it
  • guest :: login
Advanced Search
  • Search in fulltext
  • Save the selected filter for next search

Refine my results

Document type

  • Articles (2)

Institution

  • National (2)

Specific Collection

  • National Collections (2)

Language

  • English (2)

Author

  • Osterwalder, B. (2) disable the filter
  • Van Cutsem, E. (2)
  • Abt, M. (1)
  • Bajetta, E. (1)
  • Blum, J. L. (1)
  • Boyer, M. (1)
  • Bugat, R. (1)
  • Burger, U. (1)
  • Cassidy, J. (1)
  • Garin, A. (1)
  • Graeven, U. (1)
  • Hoff, P. (1)
  • Hoff, P. M. (1)
  • Maroun, J. (1)
  • Marshall, J. (1)
  • McKendrick, J. (1)
  • Pérez-Manga, G. (1)
  • Rosso, R. (1)
  • Rougier, P. (1)
  • Schilsky, R. L. (1)
  • Twelves, C. (1)
  • More Less

Domain

  • Medicine, Technology, Engineering (2)

Keyword

  • Key words: capecitabine (1)
  • colorectal cancer (1)
  • fluoropyrimidine (1)
  • tolerability (1)
Sorted by: Date of deposit
  • Date of deposit
  • Title
  • Author

  • Ascending
  • Descending
2 results 1
Postprint
Consortium of Swiss Academic Libraries

First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin

Cassidy, J. ; Twelves, C. ; Van Cutsem, E. ; Hoff, P. ; Bajetta, E. ; Boyer, M. ; Bugat, R. ; Burger, U. ; Garin, A. ; Graeven, U. ; McKendrick, J. ; Maroun, J. ; Marshall, J. ; Osterwalder, B. ; Pérez-Manga, G. ; Rosso, R. ; Rougier, P. ; Schilsky, R. L.

In: Annals of Oncology, 2002, vol. 13, no. 4, p. 566-575

Postprint
Consortium of Swiss Academic Libraries

Incidence of cardiotoxicity with the oral fluoropyrimidine capecitabine is typical of that reported with 5-fluorouracil

Van Cutsem, E. ; Hoff, P. M. ; Blum, J. L. ; Abt, M. ; Osterwalder, B.

In: Annals of Oncology, 2002, vol. 13, no. 3, p. 484-485

2 results 1
  • Home
  • Contact
  • RERO Explore
  • Powered by Invenio
  • / © Copyright RERO